AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease Read more
AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside Read more
FDA Approves Pfizer’s XELJANZ (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis Read more
Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference Read more
FDA approves Nucala as the first and only biologic treatment for Hypereosinophilic Syndrome (HES) Read more
Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic Read more
Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist Read more